Athos Therapeutics Path to Success with MICRO-TAG® Target Engagement скачать в хорошем качестве

Athos Therapeutics Path to Success with MICRO-TAG® Target Engagement

This is an exclusive webinar featuring Athos Therapeutics as they share their real-world experience applying MICRO-TAG® cell target engagement platform in an end-to-end drug discovery workflow. In this session, Athos Therapeutics’ Chief Scientific Officer, Dr. Iordanis Karagiannidis, presents how the collaboration enabled Athos to: Identify and map drug targets Generate MICRO-TAG reporter cell lines for candidate targets Establish thermal signatures and stability profiles of targets Quantify target engagement potency and selectivity for lead compound Develop smart drug discovery program This integrated approach resulted in definitive confirmation of the primary drug target, giving Athos the confidence to advance into lead optimization and preclinical development. Hear directly from Dr. Karagiannidis about how MICRO-TAG accelerated decision-making, reduced uncertainty, and strengthened Athos Therapeutics’ therapeutic strategy. This webinar is ideal for: Scientists at all levels Leaders of preclinical drug discovery programs Fellow scientists interested in drug discovery www.cellarisbio.com